Novavax's Unattributed VC - II Round

Novavax raised a round of funding on November 08, 2005.

Novavax, Inc. (Nasdaq: NVAX) is a clinical stage biotechnology company, creating novel vaccines to address a broad range of infectious diseases worldwide using advanced proprietary virus-like particle…

Articles about Novavax's Unattributed VC - II Round: